Leo E. Otterbein, Ph.D.
Affiliations: | 2000 | Johns Hopkins University, Baltimore, MD |
Area:
Cell Biology, Animal Physiology Biology, ImmunologyGoogle:
"Leo Otterbein"Parents
Sign in to add mentor| Steve Kleeberger | grad student | 2000 | Johns Hopkins | |
| (Carbon monoxide: The potential mechanism of cytoprotection conferred by heme oxygenase-1.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tift MS, Alves de Souza RW, Weber J, et al. (2020) Adaptive Potential of the Heme Oxygenase/Carbon Monoxide Pathway During Hypoxia. Frontiers in Physiology. 11: 886 |
| Cahill LA, Guo F, Nguyen J, et al. (2020) Circulating Factors in Trauma Plasma Activate Specific Human Immune Cell Subsets. Injury |
| Hanidziar D, Nakahori Y, Cahill LA, et al. (2020) Characterization of pulmonary immune responses to hyperoxia by high-dimensional mass cytometry analyses. Scientific Reports. 10: 4677 |
| Yang X, de Caestecker M, Otterbein LE, et al. (2019) Carbon monoxide: An emerging therapy for acute kidney injury. Medicinal Research Reviews |
| Cyr A, Chambers L, Waltz PK, et al. (2019) Endotoxin Engages Mitochondrial Quality Control an iNOS-Reactive Oxygen Species Signaling Pathway in Hepatocytes. Oxidative Medicine and Cellular Longevity. 2019: 4745067 |
| Lee GR, Shaefi S, Otterbein LE. (2019) HO-1 and CD39: It Takes Two to Protect the Realm. Frontiers in Immunology. 10: 1765 |
| Bisht K, Canesin G, Cheytan T, et al. (2019) Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway. Journal of Immunology (Baltimore, Md. : 1950) |
| Belcher JD, Gomperts E, Nguyen J, et al. (2018) Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia. Plos One. 13: e0205194 |
| Xie A, Robles RJ, Mukherjee S, et al. (2018) HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease. Journal of Autoimmunity |
| Hopper CP, Meinel L, Steiger C, et al. (2018) Where is the Clinical Breakthrough of Heme Oxygenase-1 / Carbon Monoxide Therapeutics? Current Pharmaceutical Design |